News Biocon Limited

Equities

BIOCON

INE376G01013

Delayed NSE India S.E. Other stock markets 04:33:14 2024-06-10 am EDT			5-day change	1st Jan Change
342.8 ^INR	+2.04%		+10.61%	+37.19%

Jun. 07	AbbVie's tight grip on Humira market raises concerns about biosimilars	RE
May. 31	Biocon Limited Receives Show Cause Notice from the Assistant Commissioner of Customs, Chennai	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Biocon Foundation conducts awareness session in 14 Government Schools	Jun. 07	AQ
AbbVie's tight grip on Humira market raises concerns about biosimilars	Jun. 07	RE
Biocon Limited Receives Show Cause Notice from the Assistant Commissioner of Customs, Chennai	May. 31	CI
INDIA STOCKS-Indian shares surrender gains as U.S. rate worries weigh	May. 24	RE
Biocon Ties Up with Handok to Market Anti-Diabetic Drug Liraglutide in South Korea	May. 24	MT
Biocon Limited Signs Exclusive Licensing and Supply Deal for the Commercialization of Liraglutide in South Korea with Handok Inc	May. 23	CI
US FDA Approves Samsung Bioepis' Eye Disease Drug Opuviz	May. 23	MT
Jefferies Adjusts Biocon’s Price Target to INR230 From INR250, Keeps at Underperform	May. 17	MT
Biocon's Consolidated Net Profit Declines in Fiscal Q4	May. 17	MT
India's Biocon posts Q4 profit fall as higher raw material costs bite	May. 16	RE
Transcript : Biocon Limited, Q4 2024 Earnings Call, May 16, 2024	May. 16
Biocon Limited Proposes Final Dividend for the Financial Year Ended March 31, 2024, Payable on or Before September 6, 2024	May. 16	CI
Biocon Limited Reports Earnings Results for the Full Year Ended March 31, 2024	May. 16	CI
Biocon Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2024	May. 16	CI
Biocon Limited signs semi-exclusive distribution and supply deal for the commercialization of generic Saxenda in Mexico with Medix	May. 13	AQ
Biocon Signs Deal with Medix for Commercialization of Chronic Weight Management Drug in Mexico	May. 13	MT
Biocon Limited Signs Semi-Exclusive Distribution and Supply Deal for the Commercialization of Generic Saxenda® (Liraglutide) in Mexico with Medix	May. 12	CI
Biocon Limited Receives Demand Orders from Assistant Commissioner of State Tax Guwahati, Assam and Sales Tax Officer Class II/Avato, Ward 41, Zone 3, Delhi	May. 01	CI
Biocon Limited Receives Demand Orders from the Office of Deputy State Tax Officer-1, Purasawakkam Assessment Circle, Chennai and Assistant Commissioner, Commercial Taxes Department, Visakhapatnam II Division	Apr. 30	CI
Natural Biocon (India) CFO Passes Away	Apr. 30	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Biocon Limited

Equities

BIOCON

INE376G01013

Summary

Filters